blindness and glp 1 Doctor Explains Risk (Should You Be Worried?) GLP-1 Agonists—commonly used for weight
Description
A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults
Nausea is one of the most common and uncomfortable side effects of GLP-1 therapy
In most major obesity trials, GLP-1 therapy was: Escalated to high or maximum tolerated doses Stopped abruptly, not down-titrated Followed by little or no continuation of structured lifestyle support In the STEP-1 extension trial (semaglutide 2.4 mg), participants who discontinued therapy regained approximately two-thirds of their prior weight loss over the following year
Tried Sprout Health
